ATI PN PHARMACOLOGY PROCTORED EXAM V5 2026/2027 - 400 VERIFIED QUESTIONS WITH
MIXED ANSWERS A,B,C,D & RATIONALES | A+ GRADED - NO REPEAT
Course: ATI PN Pharmacology Proctored V5 2026/2027 | 400Q Mixed A/B/C/D: A=107 B=91 C=106 D=96 | 2026/2027 - No
Repeat Edition
9 new versions - 100% unique questions - no repeat from previous PN Pharm file. Original 2026/2027 content, mixed keys.
1. [V5] Ibuprofen contraindication? - Case 1 PN Pharm 2026/2027
A. Avoid in ulcer, GI bleed, kidney disease, pregnancy 3rd trimester, bleeding risk
B. No risk
C. Safe always
D. No contraindication
Answer: A
Rationale: NSAID contraindications GI bleed, renal. - Version 5 2026/2027
2. [V5] Levothyroxine teaching? - Case 2 PN Pharm 2026/2027
A. Take with milk
B. Take with iron
C. Take with food, at night
D. Take 30-60 min before breakfast on empty stomach, same time daily
Answer: D
Rationale: Levo empty stomach, no soy, iron, calcium within 4h. - Version 5 2026/2027
3. [V5] Morphine side effects PN monitor? - Case 3 PN Pharm 2026/2027
A. No effects
B. Diarrhea
C. Respiratory depression, sedation, constipation, hypotension, pinpoint pupils
D. Tachycardia only
Answer: C
Rationale: Opioid side effects resp depression. - Version 5 2026/2027
4. [V5] A client taking amlodipine reports ankle swelling. Best response? - Case 4 PN Pharm 2026/2027
A. Ankle swelling common with amlodipine - elevate legs, notify provider if worsens, monitor BP
B. Stop drug immediately
C. Take double dose
D. No action
Answer: A
Rationale: CCB amlodipine causes peripheral edema - elevate legs, monitor. - Version 5 2026/2027
5. [V5] Psyllium teaching? - Case 5 PN Pharm 2026/2027
A. Take with full glass water, may cause bloating, fiber
B. At bedtime only
C. Take dry
D. No water
Answer: A
Rationale: Psyllium needs water. - Version 5 2026/2027
6. [V5] Acetaminophen max dose PN? - Case 6 PN Pharm 2026/2027
A. 8g
B. 10g/day
C. 3-4g/day adult max - liver toxicity >4g, avoid alcohol
D. No max
Answer: C
Rationale: Acetaminophen max 3-4g/day. - Version 5 2026/2027
7. [V5] Prednisone long-term side effects? - Case 7 PN Pharm 2026/2027
A. Hypoglycemia
B. Weight gain, hyperglycemia, moon face, buffalo hump, osteoporosis, infection risk
C. Weight loss
D. No effects
Answer: B
Rationale: Steroids cause Cushingoid appearance, hyperglycemia, osteoporosis. - Version 5 2026/2027
8. [V5] Albuterol side effects? - Case 8 PN Pharm 2026/2027
A. Weight gain
B. Tachycardia, tremor, nervousness - beta2 agonist
C. Cough always
, D. Bradycardia
Answer: B
Rationale: Albuterol tachycardia, tremor. - Version 5 2026/2027
9. [V5] LPN cannot do IV push - Case 9 PN Pharm 2026/2027
A. Can do IV push
B. LPN cannot do IV push meds, initial assessment, teaching, unstable clients
C. Can do all
D. Can do assessment
Answer: B
Rationale: LPN scope no IV push, no initial assessment. - Version 5 2026/2027
10. [V5] Epinephrine use in anaphylaxis? - Case 10 PN Pharm 2026/2027
A. No use
B. Bradycardia only
C. Anaphylaxis first-line - IM in mid-thigh, bronchodilation, vasoconstriction
D. Hypotension only
Answer: C
Rationale: Epi first in anaphylaxis IM. - Version 5 2026/2027
11. [V5] Phenytoin teaching? - Case 11 PN Pharm 2026/2027
A. No hygiene
B. Skip doses
C. Good oral hygiene, avoid alcohol, therapeutic 10-20 mcg/mL, gum hyperplasia risk
D. Double dose if missed
Answer: C
Rationale: Phenytoin gum hyperplasia, hygiene. - Version 5 2026/2027
12. [V5] Ipratropium (Atrovent) teaching? - Case 12 PN Pharm 2026/2027
A. No teaching
B. Avoid if peanut allergy - contains soy lecithin, rinse mouth
C. No rinse
D. Take with food
Answer: B
Rationale: Ipratropium caution peanut/soy allergy, rinse mouth. - Version 5 2026/2027
13. [V5] Haloperidol EPS treatment? - Case 13 PN Pharm 2026/2027
A. No monitor
B. Stop water
C. No treatment
D. Benztropine/diphenhydramine for acute dystonia, monitor EPS
Answer: D
Rationale: Antipsychotic EPS benztropine. - Version 5 2026/2027
14. [V5] Opioid overdose antidote? - Case 14 PN Pharm 2026/2027
A. Protamine
B. Vitamin K
C. Naloxone - may need repeat due to short half-life
D. Flumazenil
Answer: C
Rationale: Naloxone opioid antagonist, monitor for re-sedation. - Version 5 2026/2027
15. [V5] Levodopa-carbidopa teaching? - Case 15 PN Pharm 2026/2027
A. Take with high protein
B. No teaching
C. Take with milk only
D. Take low protein, avoid high protein reduces absorption, dark sweat/urine normal
Answer: D
Rationale: Levodopa low protein diet. - Version 5 2026/2027
16. [V5] Docusate use? - Case 16 PN Pharm 2026/2027
A. Pain
B. Stool softener - softens stool, needs fluids
C. Fever
D. Stimulant
Answer: B
Rationale: Docusate softener. - Version 5 2026/2027
17. [V5] Acetaminophen overdose antidote? - Case 17 PN Pharm 2026/2027
, A. Naloxone
B. Protamine
C. N-acetylcysteine (NAC) within 8 hours
D. Vitamin K
Answer: C
Rationale: NAC replenishes glutathione in acetaminophen toxicity. - Version 5 2026/2027
18. [V5] Bisacodyl use? - Case 18 PN Pharm 2026/2027
A. Constipation - stimulant laxative
B. Pain
C. Diarrhea
D. Fever
Answer: A
Rationale: Stimulant laxative. - Version 5 2026/2027
19. [V5] Potassium chloride administration? - Case 19 PN Pharm 2026/2027
A. Give fast
B. No monitor
C. Never IV push - dilute, give via pump, check kidney function, monitor EKG
D. IV push
Answer: C
Rationale: KCl never IV push, dilute. - Version 5 2026/2027
20. [V5] Ciprofloxacin teaching? - Case 20 PN Pharm 2026/2027
A. Take at bedtime only
B. Avoid antacids, iron, dairy within 2h, drink fluids, avoid sun - tendon rupture risk
C. No teaching
D. Take with milk
Answer: B
Rationale: Cipro avoid cations, sun, tendon risk. - Version 5 2026/2027
21. [V5] Benzodiazepine overdose antidote? - Case 21 PN Pharm 2026/2027
A. Vitamin K
B. Protamine
C. Flumazenil
D. Naloxone
Answer: C
Rationale: Flumazenil reverses benzos, risk seizures. - Version 5 2026/2027
22. [V5] Atropine use? - Case 22 PN Pharm 2026/2027
A. No use
B. Tachycardia
C. Bradycardia symptomatic, organophosphate poisoning antidote
D. Hypertension
Answer: C
Rationale: Atropine increases HR in symptomatic bradycardia. - Version 5 2026/2027
23. [V5] Heparin antidote? - Case 23 PN Pharm 2026/2027
A. Protamine sulfate
B. Vitamin K
C. Naloxone
D. Flumazenil
Answer: A
Rationale: Protamine binds heparin. - Version 5 2026/2027
24. [V5] Insulin lispro onset? - Case 24 PN Pharm 2026/2027
A. 15 minutes rapid-acting, peak 1-2h, duration 3-4h
B. 2 hours
C. 12 hours
D. 6 hours
Answer: A
Rationale: Lispro rapid 15 min onset. - Version 5 2026/2027
25. [V5] Montelukast when to take? - Case 25 PN Pharm 2026/2027
A. No timing
B. During attack only
C. Morning only
D. Evening - asthma prophylaxis, not rescue
, Answer: D
Rationale: Montelukast evening daily, not rescue. - Version 5 2026/2027
26. [V5] Warfarin antidote for bleeding? - Case 26 PN Pharm 2026/2027
A. Naloxone
B. Calcium
C. Vitamin K + 4F-PCC for life-threatening
D. Protamine
Answer: C
Rationale: Vitamin K for warfarin reversal, PCC for severe bleed. - Version 5 2026/2027
27. [V5] Omeprazole teaching? - Case 27 PN Pharm 2026/2027
A. No risk
B. Take 30 min before breakfast, long-term risk fractures, low Mg2+
C. Take with food always
D. Double dose
Answer: B
Rationale: PPI before breakfast. - Version 5 2026/2027
28. [V5] Fluoxetine (SSRI) onset? - Case 28 PN Pharm 2026/2027
A. No onset
B. 2-4 weeks for full effect, watch for increased suicidal ideation early
C. 1 hour
D. Immediate
Answer: B
Rationale: SSRI 2-4 weeks, black box suicide early. - Version 5 2026/2027
29. [V5] Glargine (Lantus) rule? - Case 29 PN Pharm 2026/2027
A. Do not mix, given at same time daily, no peak - basal insulin
B. IV push
C. Give with meals only
D. Mix with regular
Answer: A
Rationale: Glargine long-acting no mix, basal. - Version 5 2026/2027
30. [V5] PN role in blood transfusion? - Case 30 PN Pharm 2026/2027
A. Monitor transfusion, vitals q15min, stop if reaction, notify RN/provider
B. Crossmatch
C. Start transfusion
D. Order blood
Answer: A
Rationale: PN monitors transfusion, stops if reaction. - Version 5 2026/2027
31. [V5] Gentamicin toxicity? - Case 31 PN Pharm 2026/2027
A. Weight gain
B. No toxicity
C. Hyperkalemia only
D. Nephrotoxicity (creatinine/BUN) and ototoxicity (hearing/tinnitus)
Answer: D
Rationale: Aminoglycoside nephro/oto. - Version 5 2026/2027
32. [V5] Lisinopril causes dry cough due to? - Case 32 PN Pharm 2026/2027
A. K+ loss
B. Na retention
C. Histamine
D. Bradykinin accumulation in lungs - ACE inhibitor side effect
Answer: D
Rationale: ACE cough from bradykinin. Switch to ARB if intolerable. - Version 5 2026/2027
33. [V5] Hypoglycemia treatment conscious PN? - Case 33 PN Pharm 2026/2027
A. Water
B. No treatment
C. Give insulin
D. 15g fast carb juice/glucose tabs, recheck 15 min, repeat if <70
Answer: D
Rationale: Rule of 15 for hypo. - Version 5 2026/2027
34. [V5] Lithium therapeutic level? - Case 34 PN Pharm 2026/2027
A. 0.1
MIXED ANSWERS A,B,C,D & RATIONALES | A+ GRADED - NO REPEAT
Course: ATI PN Pharmacology Proctored V5 2026/2027 | 400Q Mixed A/B/C/D: A=107 B=91 C=106 D=96 | 2026/2027 - No
Repeat Edition
9 new versions - 100% unique questions - no repeat from previous PN Pharm file. Original 2026/2027 content, mixed keys.
1. [V5] Ibuprofen contraindication? - Case 1 PN Pharm 2026/2027
A. Avoid in ulcer, GI bleed, kidney disease, pregnancy 3rd trimester, bleeding risk
B. No risk
C. Safe always
D. No contraindication
Answer: A
Rationale: NSAID contraindications GI bleed, renal. - Version 5 2026/2027
2. [V5] Levothyroxine teaching? - Case 2 PN Pharm 2026/2027
A. Take with milk
B. Take with iron
C. Take with food, at night
D. Take 30-60 min before breakfast on empty stomach, same time daily
Answer: D
Rationale: Levo empty stomach, no soy, iron, calcium within 4h. - Version 5 2026/2027
3. [V5] Morphine side effects PN monitor? - Case 3 PN Pharm 2026/2027
A. No effects
B. Diarrhea
C. Respiratory depression, sedation, constipation, hypotension, pinpoint pupils
D. Tachycardia only
Answer: C
Rationale: Opioid side effects resp depression. - Version 5 2026/2027
4. [V5] A client taking amlodipine reports ankle swelling. Best response? - Case 4 PN Pharm 2026/2027
A. Ankle swelling common with amlodipine - elevate legs, notify provider if worsens, monitor BP
B. Stop drug immediately
C. Take double dose
D. No action
Answer: A
Rationale: CCB amlodipine causes peripheral edema - elevate legs, monitor. - Version 5 2026/2027
5. [V5] Psyllium teaching? - Case 5 PN Pharm 2026/2027
A. Take with full glass water, may cause bloating, fiber
B. At bedtime only
C. Take dry
D. No water
Answer: A
Rationale: Psyllium needs water. - Version 5 2026/2027
6. [V5] Acetaminophen max dose PN? - Case 6 PN Pharm 2026/2027
A. 8g
B. 10g/day
C. 3-4g/day adult max - liver toxicity >4g, avoid alcohol
D. No max
Answer: C
Rationale: Acetaminophen max 3-4g/day. - Version 5 2026/2027
7. [V5] Prednisone long-term side effects? - Case 7 PN Pharm 2026/2027
A. Hypoglycemia
B. Weight gain, hyperglycemia, moon face, buffalo hump, osteoporosis, infection risk
C. Weight loss
D. No effects
Answer: B
Rationale: Steroids cause Cushingoid appearance, hyperglycemia, osteoporosis. - Version 5 2026/2027
8. [V5] Albuterol side effects? - Case 8 PN Pharm 2026/2027
A. Weight gain
B. Tachycardia, tremor, nervousness - beta2 agonist
C. Cough always
, D. Bradycardia
Answer: B
Rationale: Albuterol tachycardia, tremor. - Version 5 2026/2027
9. [V5] LPN cannot do IV push - Case 9 PN Pharm 2026/2027
A. Can do IV push
B. LPN cannot do IV push meds, initial assessment, teaching, unstable clients
C. Can do all
D. Can do assessment
Answer: B
Rationale: LPN scope no IV push, no initial assessment. - Version 5 2026/2027
10. [V5] Epinephrine use in anaphylaxis? - Case 10 PN Pharm 2026/2027
A. No use
B. Bradycardia only
C. Anaphylaxis first-line - IM in mid-thigh, bronchodilation, vasoconstriction
D. Hypotension only
Answer: C
Rationale: Epi first in anaphylaxis IM. - Version 5 2026/2027
11. [V5] Phenytoin teaching? - Case 11 PN Pharm 2026/2027
A. No hygiene
B. Skip doses
C. Good oral hygiene, avoid alcohol, therapeutic 10-20 mcg/mL, gum hyperplasia risk
D. Double dose if missed
Answer: C
Rationale: Phenytoin gum hyperplasia, hygiene. - Version 5 2026/2027
12. [V5] Ipratropium (Atrovent) teaching? - Case 12 PN Pharm 2026/2027
A. No teaching
B. Avoid if peanut allergy - contains soy lecithin, rinse mouth
C. No rinse
D. Take with food
Answer: B
Rationale: Ipratropium caution peanut/soy allergy, rinse mouth. - Version 5 2026/2027
13. [V5] Haloperidol EPS treatment? - Case 13 PN Pharm 2026/2027
A. No monitor
B. Stop water
C. No treatment
D. Benztropine/diphenhydramine for acute dystonia, monitor EPS
Answer: D
Rationale: Antipsychotic EPS benztropine. - Version 5 2026/2027
14. [V5] Opioid overdose antidote? - Case 14 PN Pharm 2026/2027
A. Protamine
B. Vitamin K
C. Naloxone - may need repeat due to short half-life
D. Flumazenil
Answer: C
Rationale: Naloxone opioid antagonist, monitor for re-sedation. - Version 5 2026/2027
15. [V5] Levodopa-carbidopa teaching? - Case 15 PN Pharm 2026/2027
A. Take with high protein
B. No teaching
C. Take with milk only
D. Take low protein, avoid high protein reduces absorption, dark sweat/urine normal
Answer: D
Rationale: Levodopa low protein diet. - Version 5 2026/2027
16. [V5] Docusate use? - Case 16 PN Pharm 2026/2027
A. Pain
B. Stool softener - softens stool, needs fluids
C. Fever
D. Stimulant
Answer: B
Rationale: Docusate softener. - Version 5 2026/2027
17. [V5] Acetaminophen overdose antidote? - Case 17 PN Pharm 2026/2027
, A. Naloxone
B. Protamine
C. N-acetylcysteine (NAC) within 8 hours
D. Vitamin K
Answer: C
Rationale: NAC replenishes glutathione in acetaminophen toxicity. - Version 5 2026/2027
18. [V5] Bisacodyl use? - Case 18 PN Pharm 2026/2027
A. Constipation - stimulant laxative
B. Pain
C. Diarrhea
D. Fever
Answer: A
Rationale: Stimulant laxative. - Version 5 2026/2027
19. [V5] Potassium chloride administration? - Case 19 PN Pharm 2026/2027
A. Give fast
B. No monitor
C. Never IV push - dilute, give via pump, check kidney function, monitor EKG
D. IV push
Answer: C
Rationale: KCl never IV push, dilute. - Version 5 2026/2027
20. [V5] Ciprofloxacin teaching? - Case 20 PN Pharm 2026/2027
A. Take at bedtime only
B. Avoid antacids, iron, dairy within 2h, drink fluids, avoid sun - tendon rupture risk
C. No teaching
D. Take with milk
Answer: B
Rationale: Cipro avoid cations, sun, tendon risk. - Version 5 2026/2027
21. [V5] Benzodiazepine overdose antidote? - Case 21 PN Pharm 2026/2027
A. Vitamin K
B. Protamine
C. Flumazenil
D. Naloxone
Answer: C
Rationale: Flumazenil reverses benzos, risk seizures. - Version 5 2026/2027
22. [V5] Atropine use? - Case 22 PN Pharm 2026/2027
A. No use
B. Tachycardia
C. Bradycardia symptomatic, organophosphate poisoning antidote
D. Hypertension
Answer: C
Rationale: Atropine increases HR in symptomatic bradycardia. - Version 5 2026/2027
23. [V5] Heparin antidote? - Case 23 PN Pharm 2026/2027
A. Protamine sulfate
B. Vitamin K
C. Naloxone
D. Flumazenil
Answer: A
Rationale: Protamine binds heparin. - Version 5 2026/2027
24. [V5] Insulin lispro onset? - Case 24 PN Pharm 2026/2027
A. 15 minutes rapid-acting, peak 1-2h, duration 3-4h
B. 2 hours
C. 12 hours
D. 6 hours
Answer: A
Rationale: Lispro rapid 15 min onset. - Version 5 2026/2027
25. [V5] Montelukast when to take? - Case 25 PN Pharm 2026/2027
A. No timing
B. During attack only
C. Morning only
D. Evening - asthma prophylaxis, not rescue
, Answer: D
Rationale: Montelukast evening daily, not rescue. - Version 5 2026/2027
26. [V5] Warfarin antidote for bleeding? - Case 26 PN Pharm 2026/2027
A. Naloxone
B. Calcium
C. Vitamin K + 4F-PCC for life-threatening
D. Protamine
Answer: C
Rationale: Vitamin K for warfarin reversal, PCC for severe bleed. - Version 5 2026/2027
27. [V5] Omeprazole teaching? - Case 27 PN Pharm 2026/2027
A. No risk
B. Take 30 min before breakfast, long-term risk fractures, low Mg2+
C. Take with food always
D. Double dose
Answer: B
Rationale: PPI before breakfast. - Version 5 2026/2027
28. [V5] Fluoxetine (SSRI) onset? - Case 28 PN Pharm 2026/2027
A. No onset
B. 2-4 weeks for full effect, watch for increased suicidal ideation early
C. 1 hour
D. Immediate
Answer: B
Rationale: SSRI 2-4 weeks, black box suicide early. - Version 5 2026/2027
29. [V5] Glargine (Lantus) rule? - Case 29 PN Pharm 2026/2027
A. Do not mix, given at same time daily, no peak - basal insulin
B. IV push
C. Give with meals only
D. Mix with regular
Answer: A
Rationale: Glargine long-acting no mix, basal. - Version 5 2026/2027
30. [V5] PN role in blood transfusion? - Case 30 PN Pharm 2026/2027
A. Monitor transfusion, vitals q15min, stop if reaction, notify RN/provider
B. Crossmatch
C. Start transfusion
D. Order blood
Answer: A
Rationale: PN monitors transfusion, stops if reaction. - Version 5 2026/2027
31. [V5] Gentamicin toxicity? - Case 31 PN Pharm 2026/2027
A. Weight gain
B. No toxicity
C. Hyperkalemia only
D. Nephrotoxicity (creatinine/BUN) and ototoxicity (hearing/tinnitus)
Answer: D
Rationale: Aminoglycoside nephro/oto. - Version 5 2026/2027
32. [V5] Lisinopril causes dry cough due to? - Case 32 PN Pharm 2026/2027
A. K+ loss
B. Na retention
C. Histamine
D. Bradykinin accumulation in lungs - ACE inhibitor side effect
Answer: D
Rationale: ACE cough from bradykinin. Switch to ARB if intolerable. - Version 5 2026/2027
33. [V5] Hypoglycemia treatment conscious PN? - Case 33 PN Pharm 2026/2027
A. Water
B. No treatment
C. Give insulin
D. 15g fast carb juice/glucose tabs, recheck 15 min, repeat if <70
Answer: D
Rationale: Rule of 15 for hypo. - Version 5 2026/2027
34. [V5] Lithium therapeutic level? - Case 34 PN Pharm 2026/2027
A. 0.1
